A

ABIONYX Pharma
ABNX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€41.96M
EV
€41.48M
Shares Outstanding
34.68M
Beta
1.02

Wall Street View

Analyst Rating
BUY
Analyst Target Price
€10.75
P/E 2025E
-
P/Revenue 2025E
9.24x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About ABIONYX Pharma SA

gainify

A

ABIONYX Pharma SA

ABNX

ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. It develops CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotei...

Sector

Healthcare

Industry

Biotechnology

CEO

Tupin, Cyrille

Employees

51

IPO Date

2015-03-30

Headquarters

33 43 av. Georges Pompidou Bât. D2, Balma, Midi-Pyrénées, 31130, France

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved